Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Hold
0
-$4 4551
2024
Q4
Hold
0
4567
2022
Q1
Hold
0
-$1K 4582
2021
Q4
Sell
-3
Closed -$6.52K 3073
2021
Q3
$12K Hold
3
﹤0.01% 2201
2021
Q2
$8K Hold
3
﹤0.01% 2301
2021
Q1
$6K Buy
+3
New +$4.51K ﹤0.01% 2357
2018
Q4
Sell
-22
Closed -$13K 3775
2018
Q3
$13K Buy
+22
New +$13.4K ﹤0.01% 2705

Other funds holding PAVM

IFP Advisors's PAVM Position: Q1 2025 in Review

IFP Advisors held its PAVmed (PAVM) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4551.

IFP Advisors first reported a position in PAVM in Q3 2018 and has held it in 4 quarters since. The position peaked at $13K in Q3 2018. 29 funds tracked by Wall St. Rank hold PAVM as of Q1 2025.

  • IFP Advisors held 0 shares of PAVmed worth $0 as of Q1 2025.
  • IFP Advisors left its PAVmed share count unchanged in Q1 2025.
  • PAVmed made up ﹤0.01% of IFP Advisors's portfolio in Q1 2025, its #4551 holding.
  • IFP Advisors first reported a position in PAVmed in Q3 2018 and has held it in 4 quarters since.
  • IFP Advisors's PAVmed position peaked at $13K in Q3 2018.
  • 29 funds tracked by Wall St. Rank held PAVmed as of Q1 2025.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.